Genevoyager

Wuhan, China · Founded 2022 · Privately Held (backing)

Developer of biopharmaceutical development and production systems designed for gene therapy and vaccine research purposes. Genevoyager is based in Wuhan, China and was founded in 2022. It has raised $27.9 million.

Last price · $/share
—
Implied valuation
—
Total raised
$27.9M
Last round
—

Who backs Genevoyager?

8 investors
InvestorType
Wuhan Hi-TechOther
Wuhan Huagong Venture CapitalOther
Haide Zeguang Investment—
Homsun Capital—
SDIC Venture Capital—
Shanghai Yinglian Health Industry Equity Investment—
State Development and Investment Group—
Xingkong Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Genevoyager investors

8 investors are on record for Genevoyager, including Wuhan Hi-Tech, Wuhan Huagong Venture Capital, Haide Zeguang Investment and Homsun Capital.

Free account
More of Genevoyager with a free account
  • ·Watch Genevoyager: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Genevoyager. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View